MarketBeat Compares VirnetX and AvePoint Financial Metrics
What happened
MarketBeat compared VirnetX and AvePoint, two technology companies, based on profitability, valuation, and risk. The report noted that VirnetX has a beta of 2.29, meaning its share price is 129% more volatile than the S&P 500, while AvePoint has a beta of 1.17. AvePoint also holds significantly more institutional shares at 44.5% compared to VirnetX's 10.4%.
From tickerreport.com
Why it matters
Analysts reviewed the companies and concluded that AvePoint is more favorable than VirnetX due to its stronger consensus rating and higher probable upside. The comparison highlights differences in risk profile and institutional confidence between the two firms.
From tickerreport.com
Who's involved
- MarketBeatProvided the comparative analysis and analyst recommendations
- AvePointA software vendor whose metrics were compared to VirnetX
- NasdaqThe stock exchange where AvePoint is formally listed
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- AvePointSpeculative
AvePoint might experience changes in investment demand due to the favorable consensus rating and higher probable upside cited by analysts.
Keep exploring
The entities involved
-
MarketBeat
American personal finance blog
-
AvePoint
American software vendor
Related events
- MarketBeat provided analyst recommendations and compared Rollins and UniFirst as industrial investment options.
- MarketBeat provides analyst recommendations and compares FAT Brands and Centerra Gold as materials companies.
- MarketBeat provided analyst ratings for small-cap real estate companies Comstock Holding Companies and Linkhome.
- MarketBeat provided analyst ratings for technology companies Plexus and Cemtrex.
- MarketBeat is reporting on consensus ratings for Aehr Test Systems, a company whose stock trades on the Nasdaq exchange.